Expanding Indications for Surgical Resection in Hepatocellular Carcinoma: What is the Evidence?
Hepatic resection
Hepatocellular carcinoma
Portal vein tumor thrombosis
Surgical resection
Journal
Surgical oncology clinics of North America
ISSN: 1558-5042
Titre abrégé: Surg Oncol Clin N Am
Pays: United States
ID NLM: 9211789
Informations de publication
Date de publication:
Jan 2024
Jan 2024
Historique:
medline:
13
11
2023
pubmed:
10
11
2023
entrez:
9
11
2023
Statut:
ppublish
Résumé
Hepatic resection is one of the mainstays of curative therapy for hepatocellular carcinoma (HCC). The appropriate selection of resectable candidates requires careful consideration of a multitude of factors including tumor burden (size and number of nodules, presence of vascular involvement, extrahepatic spread), patient factors (performance status, underlying liver function), and availability of other therapies (access to transplantation, interventional procedures, immunotherapies). Historically, hepatic resection for HCC has been reserved for patients with solitary tumors without vascular invasion. However, in well-selected patients HCC tumors multifocal in nature or with vascular invasion should be considered for hepatic resection.
Identifiants
pubmed: 37945148
pii: S1055-3207(23)00078-9
doi: 10.1016/j.soc.2023.07.004
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
99-109Informations de copyright
Copyright © 2023 Elsevier Inc. All rights reserved.